Accord BioPharma Launches IMULDOSA at Lowest WAC Price
August 18, 2025
Company’s third biosimilar expands access to proven targeted biologic therapy with patient-centric support services and resources Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals,